Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Academy Sports and Outdoors | ASO | 18. oct 2024 | 56.09 | +1.28 |
Acadia Healthcare | ACHC | 18. oct 2024 | 52.03 | -12.29 |
Acadia Pharmaceuticals | ACAD | 18. oct 2024 | 15.30 | +0.86 |
Acadia Realty Trust | AKR | 18. oct 2024 | 24.74 | +1.19 |
Acasti Pharma, Inc. | ACST | 18. oct 2024 | 3.33 | +1.47 |
Accel Entertainment | ACEL | 18. oct 2024 | 11.32 | -1.31 |
Accelerate Diagnostics | AXDX | 18. oct 2024 | 1.81 | +3.43 |
Accenture A | ACN | 18. oct 2024 | 376.86 | +0.46 |
Acco Brands | ACCO | 18. oct 2024 | 5.19 | -2.08 |
Accolade | ACCD | 18. oct 2024 | 3.50 | -2.23 |
Accuray | ARAY | 18. oct 2024 | 1.89 | +3.28 |
Acelyrin | SLRN | 18. oct 2024 | 6.20 | -4.32 |
Achieve Life Sciences | ACHV | 18. oct 2024 | 5.08 | +0.59 |
Achilles Therapeutics ADR | ACHL | 18. oct 2024 | 1.00 | +1.01 |
ACI Worldwide | ACIW | 18. oct 2024 | 50.66 | -2.46 |
Aclarion | ACON | 18. oct 2024 | 0.18 | +4.52 |
Aclaris Therapeutics | ACRS | 18. oct 2024 | 1.19 | +1.71 |
ACM Research A | ACMR | 18. oct 2024 | 19.21 | +1.08 |
Acme United | ACU | 18. oct 2024 | 41.20 | -5.89 |
ACNB | ACNB | 18. oct 2024 | 44.10 | -0.14 |
ACRES Commercial Realty | ACR | 18. oct 2024 | 15.67 | +2.15 |
ACRES Commercial Realty C Pref | ACR-C | 18. oct 2024 | 24.89 | +0.28 |
ACRES Commercial Realty D Pref | ACR-D | 18. oct 2024 | 23.35 | +0.41 |
Acri Capital Acquisition Unit | ACACU | 18. oct 2024 | 12.94 | 0.00 |
Acrivon Therapeutics | ACRV | 18. oct 2024 | 8.25 | +4.83 |
Actelis Networks | ASNS | 18. oct 2024 | 1.45 | +3.57 |
Actinium Pharmaceuticals | ATNM | 18. oct 2024 | 1.82 | +5.81 |
Active Bear ETF | HDGE | 18. oct 2024 | 18.03 | -0.19 |
Active U.S. Real Estate Powershares | PSR | 18. oct 2024 | 98.86 | +0.78 |
Actuate Therapeutics | ACTU | 18. oct 2024 | 7.26 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.